Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
ExQor Technologies is preparing for clinical trials of its brain regenerative medicine platform targeting Alzheimer's disease, announced in a press release. The platform shows potential to reverse brain damage and promote regeneration.
AIxMed and Biopticka Laboratoř have signed a Memorandum of Understanding to integrate AIxMed's AIxURO solution into Biopticka's laboratory system, enhancing bladder cancer diagnostics.
OncoC4, a biotechnology company, has closed a Series B financing round of nearly $50 million to advance its pipeline of cancer therapies, announced in a press release.
Psilera Inc. has received a $2 million grant from the National Institutes of Health to advance research on a novel treatment for Alcohol Use Disorder.
Elix, Inc. and Tohoku University have entered a joint research agreement to advance drug discovery using AI technologies, focusing on developing compounds for challenging protein targets.
Kyruus Health has announced a strategic partnership with Healthgrades to improve the digital presence of healthcare providers by streamlining data management and ensuring accurate provider profiles.
SafeTraces has been selected as a Prime Performer for the ARPA-H BREATHE program, leading a $39 million initiative to enhance indoor air quality through real-time biosensors and automated controls.
The Centers for Medicare & Medicaid Services has introduced a new ICD-10-PCS code for AI sepsis diagnostic technologies, including Prenosis' Sepsis ImmunoScore.
Neteera Technologies Ltd. announced that its contactless monitoring system achieved 77% sensitivity in detecting impending hospitalizations among nursing facility residents, providing an average warning of 4.99 days for clinical intervention.
Illumina has launched BioInsight, a new business unit focused on leveraging AI and data to advance life sciences, as announced in a press release. BioInsight aims to enhance drug target discovery and development by providing access to large omics datasets.
Natus Medical Incorporated has acquired the remaining shares of Holberg EEG, enhancing its neurodiagnostic AI capabilities. The acquisition aims to improve EEG interpretation accuracy and patient outcomes.
Lumonus has announced a multi-year agreement with Smarter Radiation Oncology to integrate evidence-based treatment protocols into its AI platform, enhancing radiation therapy across U.S. cancer centers.
United Imaging has announced the launch of its new digital radiography system, uDR Aurora CX, which integrates AI diagnostics and computer vision to enhance imaging procedures.
Mondego Bio, backed by Biovance Capital, Torrey Pines Investment, and OrbiMed, has launched to advance AI-driven cancer therapies.
Vee Healthtek has announced its acquisition of Precision Practice Management to enhance its AI-driven healthcare solutions, according to a press release.
Qaelon Medical has appointed Dr. Marylise Boutros to its Scientific Advisory Board, enhancing its expertise in surgical leak detection technology.
Pair Team's AI-enabled model improves Medicaid patient engagement and reduces emergency care usage, as reported in a peer-reviewed study.
Viva Biotech has been recognized with Frost & Sullivan's 2025 APAC Technology Innovation Leadership award for its AI-driven drug discovery platforms, which enhance efficiency and reduce costs in pharmaceutical R&D.
Fuse Oncology is demonstrating its AI-powered oncology workflow solutions at ASTRO 2025, highlighting its vendor-agnostic approach to improving cancer care.
Elsevier has appointed Brent Gordon as the new president of its global Healthcare Education business unit, focusing on digital learning platforms for healthcare professionals.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
